Drug Discovery Informatics - Global Market Outlook (2020-2028)
According to Stratistics MRC, the Global Drug Discovery Informatics market is accounted for $2.24 billion in 2020 and is expected to reach $5.27 billion by 2028 growing at a CAGR of 11.3% during the forecast period. Rising research & development (R&D) expenditure, growing support for research, especially in the area of rare diseases, and the increasing use of informatics in drug discovery are the major factors driving the market growth. However, the scarcity of skilled professionals is restraining the market growth.
Drug Discovery Informatics enables users to address large volume of data storage & management and further processing & analyzing the obtained results. Drug discovery informatics platforms utilize bioinformatics algorithms for processing life science data and uses various in silico models for analyzing the data obtained.
Based on function, the sequencing and target data analysis segment is estimated to have a lucrative growth due to increased application for sequencing analysis for the new drug entity and ease of handling of information from different domains and sources. By geography, North America is going to have high growth during forecast period due to the large share in the global market can be attributed to the presence of well-established contract research organization (CROs), rising R&D expenditure by pharmaceutical and biopharmaceutical companies.
Some of the key players profiled in the Drug Discovery Informatics Market include Albany Molecular Research Inc., Certara, L.P., Charles River, Selvita, Collaborative Drug Discovery, Inc, Dassault Syst?mes, GVK Biosciences Private Limited, IBM Corporation, Infosys Limited, Insilico Medicine, IO Informatics, Inc., Jubilant Life Sciences Ltd., OpenEye Scientific Software, PerkinElmer Inc., Schr?dinger, LLC and Thermo Fisher Scientific.
Types Covered:
All the customers of this report will be entitled to receive one of the following free customization options:
Drug Discovery Informatics enables users to address large volume of data storage & management and further processing & analyzing the obtained results. Drug discovery informatics platforms utilize bioinformatics algorithms for processing life science data and uses various in silico models for analyzing the data obtained.
Based on function, the sequencing and target data analysis segment is estimated to have a lucrative growth due to increased application for sequencing analysis for the new drug entity and ease of handling of information from different domains and sources. By geography, North America is going to have high growth during forecast period due to the large share in the global market can be attributed to the presence of well-established contract research organization (CROs), rising R&D expenditure by pharmaceutical and biopharmaceutical companies.
Some of the key players profiled in the Drug Discovery Informatics Market include Albany Molecular Research Inc., Certara, L.P., Charles River, Selvita, Collaborative Drug Discovery, Inc, Dassault Syst?mes, GVK Biosciences Private Limited, IBM Corporation, Infosys Limited, Insilico Medicine, IO Informatics, Inc., Jubilant Life Sciences Ltd., OpenEye Scientific Software, PerkinElmer Inc., Schr?dinger, LLC and Thermo Fisher Scientific.
Types Covered:
- In-House
- Outsourced
- Software
- Services
- Clinical Trial Data Management
- Docking
- Library & Database Preparation
- Molecular Modelling
- Screening & Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) Characterization
- Sequencing and Target Data Analysis
- Discovery Informatics
- Development Informatics
- Cloud Based Systems
- In Campus Platform
- Drug Discovery
- Drug Development
- Academic Institutes
- Biotechnology Companies
- Contract Research Organization (CROs)
- Government Organizations
- Hospital
- Pharmaceutical Companies
- University
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY TYPE
5.1 Introduction
5.2 In-House
5.3 Outsourced
6 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION
6.1 Introduction
6.2 Software
6.3 Services
7 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION
7.1 Introduction
7.2 Clinical Trial Data Management
7.3 Docking
7.4 Library & Database Preparation
7.5 Molecular Modelling
7.6 Screening & Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) Characterization
7.7 Sequencing and Target Data Analysis
8 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY INFORMATICS WORKFLOW
8.1 Introduction
8.2 Discovery Informatics
8.2.1 Identification, Validation, & Assay Development Informatics
8.2.2 Lead Generation & Validation
8.3 Development informatics
8.3.1 Lead Optimization
8.3.2 First Human Dose (FHD) Preparation
8.3.3 Phase IA Informatics
8.3.4 Phase IB/2 Informatics
9 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY MODALITY
9.1 Introduction
9.2 Cloud Based Systems
9.3 In Campus Platform
10 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION
10.1 Introduction
10.2 Drug Discovery
10.2.1 Preclinical Testing
10.2.2 Clinical Trials
10.3 Drug Development
11 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY END USER
11.1 Introduction
11.2 Academic Institutes
11.3 Biotechnology Companies
11.4 Contract Research Organization (CROs)
11.5 Government Organizations
11.6 Hospital
11.7 Pharmaceutical Companies
11.8 University
12 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY GEOGRAPHY
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 New Zealand
12.4.6 South Korea
12.4.7 Rest of Asia Pacific
12.5 South America
12.5.1 Argentina
12.5.2 Brazil
12.5.3 Chile
12.5.4 Rest of South America
12.6 Middle East & Africa
12.6.1 Saudi Arabia
12.6.2 UAE
12.6.3 Qatar
12.6.4 South Africa
12.6.5 Rest of Middle East & Africa
13 KEY DEVELOPMENTS
13.1 Agreements, Partnerships, Collaborations and Joint Ventures
13.2 Acquisitions & Mergers
13.3 New Product Launch
13.4 Expansions
13.5 Other Key Strategies
14 COMPANY PROFILING
14.1 Albany Molecular Research Inc.
14.2 Certara, L.P.
14.3 Charles River, Selvita
14.4 Collaborative Drug Discovery, Inc
14.5 Dassault Syst?mes
14.6 GVK Biosciences Private Limited
14.7 IBM Corporation
14.8 Infosys Limited
14.9 Insilico Medicine
14.10 IO Informatics, Inc.
14.11 Jubilant Life Sciences Ltd.
14.12 OpenEye Scientific Software
14.13 PerkinElmer Inc.
14.14 Schr?dinger, LLC
14.15 Thermo Fisher Scientific
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY TYPE
5.1 Introduction
5.2 In-House
5.3 Outsourced
6 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION
6.1 Introduction
6.2 Software
6.3 Services
7 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION
7.1 Introduction
7.2 Clinical Trial Data Management
7.3 Docking
7.4 Library & Database Preparation
7.5 Molecular Modelling
7.6 Screening & Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) Characterization
7.7 Sequencing and Target Data Analysis
8 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY INFORMATICS WORKFLOW
8.1 Introduction
8.2 Discovery Informatics
8.2.1 Identification, Validation, & Assay Development Informatics
8.2.2 Lead Generation & Validation
8.3 Development informatics
8.3.1 Lead Optimization
8.3.2 First Human Dose (FHD) Preparation
8.3.3 Phase IA Informatics
8.3.4 Phase IB/2 Informatics
9 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY MODALITY
9.1 Introduction
9.2 Cloud Based Systems
9.3 In Campus Platform
10 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION
10.1 Introduction
10.2 Drug Discovery
10.2.1 Preclinical Testing
10.2.2 Clinical Trials
10.3 Drug Development
11 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY END USER
11.1 Introduction
11.2 Academic Institutes
11.3 Biotechnology Companies
11.4 Contract Research Organization (CROs)
11.5 Government Organizations
11.6 Hospital
11.7 Pharmaceutical Companies
11.8 University
12 GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY GEOGRAPHY
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 New Zealand
12.4.6 South Korea
12.4.7 Rest of Asia Pacific
12.5 South America
12.5.1 Argentina
12.5.2 Brazil
12.5.3 Chile
12.5.4 Rest of South America
12.6 Middle East & Africa
12.6.1 Saudi Arabia
12.6.2 UAE
12.6.3 Qatar
12.6.4 South Africa
12.6.5 Rest of Middle East & Africa
13 KEY DEVELOPMENTS
13.1 Agreements, Partnerships, Collaborations and Joint Ventures
13.2 Acquisitions & Mergers
13.3 New Product Launch
13.4 Expansions
13.5 Other Key Strategies
14 COMPANY PROFILING
14.1 Albany Molecular Research Inc.
14.2 Certara, L.P.
14.3 Charles River, Selvita
14.4 Collaborative Drug Discovery, Inc
14.5 Dassault Syst?mes
14.6 GVK Biosciences Private Limited
14.7 IBM Corporation
14.8 Infosys Limited
14.9 Insilico Medicine
14.10 IO Informatics, Inc.
14.11 Jubilant Life Sciences Ltd.
14.12 OpenEye Scientific Software
14.13 PerkinElmer Inc.
14.14 Schr?dinger, LLC
14.15 Thermo Fisher Scientific
LIST OF TABLES
Table 1 Global Drug Discovery Informatics Market Outlook, By Region (2019-2028) (US $MN)
Table 2 Global Drug Discovery Informatics Market Outlook, By Type (2019-2028) (US $MN)
Table 3 Global Drug Discovery Informatics Market Outlook, By In-House (2019-2028) (US $MN)
Table 4 Global Drug Discovery Informatics Market Outlook, By Outsourced (2019-2028) (US $MN)
Table 5 Global Drug Discovery Informatics Market Outlook, By Solution (2019-2028) (US $MN)
Table 6 Global Drug Discovery Informatics Market Outlook, By Software (2019-2028) (US $MN)
Table 7 Global Drug Discovery Informatics Market Outlook, By Services (2019-2028) (US $MN)
Table 8 Global Drug Discovery Informatics Market Outlook, By Function (2019-2028) (US $MN)
Table 9 Global Drug Discovery Informatics Market Outlook, By Clinical Trial Data Management (2019-2028) (US $MN)
Table 10 Global Drug Discovery Informatics Market Outlook, By Docking (2019-2028) (US $MN)
Table 11 Global Drug Discovery Informatics Market Outlook, By Library & Database Preparation (2019-2028) (US $MN)
Table 12 Global Drug Discovery Informatics Market Outlook, By Molecular Modelling (2019-2028) (US $MN)
Table 13 Global Drug Discovery Informatics Market Outlook, By Screening & Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) Characterization (2019-2028) (US $MN)
Table 14 Global Drug Discovery Informatics Market Outlook, By Sequencing and Target Data Analysis (2019-2028) (US $MN)
Table 15 Global Drug Discovery Informatics Market Outlook, By Informatics Workflow (2019-2028) (US $MN)
Table 16 Global Drug Discovery Informatics Market Outlook, By Discovery Informatics (2019-2028) (US $MN)
Table 17 Global Drug Discovery Informatics Market Outlook, By Identification, Validation, & Assay Development Informatics (2019-2028) (US $MN)
Table 18 Global Drug Discovery Informatics Market Outlook, By Lead Generation & Validation (2019-2028) (US $MN)
Table 19 Global Drug Discovery Informatics Market Outlook, By Development Informatics (2019-2028) (US $MN)
Table 20 Global Drug Discovery Informatics Market Outlook, By Lead Optimization (2019-2028) (US $MN)
Table 21 Global Drug Discovery Informatics Market Outlook, By First Human Dose (FHD) Preparation (2019-2028) (US $MN)
Table 22 Global Drug Discovery Informatics Market Outlook, By Phase IA Informatics (2019-2028) (US $MN)
Table 23 Global Drug Discovery Informatics Market Outlook, By Phase IB/2 Informatics (2019-2028) (US $MN)
Table 24 Global Drug Discovery Informatics Market Outlook, By Modality (2019-2028) (US $MN)
Table 25 Global Drug Discovery Informatics Market Outlook, By Cloud Based Systems (2019-2028) (US $MN)
Table 26 Global Drug Discovery Informatics Market Outlook, By In Campus Platform (2019-2028) (US $MN)
Table 27 Global Drug Discovery Informatics Market Outlook, By Application (2019-2028) (US $MN)
Table 28 Global Drug Discovery Informatics Market Outlook, By Drug Discovery (2019-2028) (US $MN)
Table 29 Global Drug Discovery Informatics Market Outlook, By Preclinical Testing (2019-2028) (US $MN)
Table 30 Global Drug Discovery Informatics Market Outlook, By Clinical Trials (2019-2028) (US $MN)
Table 31 Global Drug Discovery Informatics Market Outlook, By Drug Development (2019-2028) (US $MN)
Table 32 Global Drug Discovery Informatics Market Outlook, By End User (2019-2028) (US $MN)
Table 33 Global Drug Discovery Informatics Market Outlook, By Academic Institutes (2019-2028) (US $MN)
Table 34 Global Drug Discovery Informatics Market Outlook, By Biotechnology Companies (2019-2028) (US $MN)
Table 35 Global Drug Discovery Informatics Market Outlook, By Contract Research Organization (CROs) (2019-2028) (US $MN)
Table 36 Global Drug Discovery Informatics Market Outlook, By Government Organizations (2019-2028) (US $MN)
Table 37 Global Drug Discovery Informatics Market Outlook, By Hospital (2019-2028) (US $MN)
Table 38 Global Drug Discovery Informatics Market Outlook, By Pharmaceutical Companies (2019-2028) (US $MN)
Table 39 Global Drug Discovery Informatics Market Outlook, By University (2019-2028) (US $MN)
Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner as above.
Table 1 Global Drug Discovery Informatics Market Outlook, By Region (2019-2028) (US $MN)
Table 2 Global Drug Discovery Informatics Market Outlook, By Type (2019-2028) (US $MN)
Table 3 Global Drug Discovery Informatics Market Outlook, By In-House (2019-2028) (US $MN)
Table 4 Global Drug Discovery Informatics Market Outlook, By Outsourced (2019-2028) (US $MN)
Table 5 Global Drug Discovery Informatics Market Outlook, By Solution (2019-2028) (US $MN)
Table 6 Global Drug Discovery Informatics Market Outlook, By Software (2019-2028) (US $MN)
Table 7 Global Drug Discovery Informatics Market Outlook, By Services (2019-2028) (US $MN)
Table 8 Global Drug Discovery Informatics Market Outlook, By Function (2019-2028) (US $MN)
Table 9 Global Drug Discovery Informatics Market Outlook, By Clinical Trial Data Management (2019-2028) (US $MN)
Table 10 Global Drug Discovery Informatics Market Outlook, By Docking (2019-2028) (US $MN)
Table 11 Global Drug Discovery Informatics Market Outlook, By Library & Database Preparation (2019-2028) (US $MN)
Table 12 Global Drug Discovery Informatics Market Outlook, By Molecular Modelling (2019-2028) (US $MN)
Table 13 Global Drug Discovery Informatics Market Outlook, By Screening & Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) Characterization (2019-2028) (US $MN)
Table 14 Global Drug Discovery Informatics Market Outlook, By Sequencing and Target Data Analysis (2019-2028) (US $MN)
Table 15 Global Drug Discovery Informatics Market Outlook, By Informatics Workflow (2019-2028) (US $MN)
Table 16 Global Drug Discovery Informatics Market Outlook, By Discovery Informatics (2019-2028) (US $MN)
Table 17 Global Drug Discovery Informatics Market Outlook, By Identification, Validation, & Assay Development Informatics (2019-2028) (US $MN)
Table 18 Global Drug Discovery Informatics Market Outlook, By Lead Generation & Validation (2019-2028) (US $MN)
Table 19 Global Drug Discovery Informatics Market Outlook, By Development Informatics (2019-2028) (US $MN)
Table 20 Global Drug Discovery Informatics Market Outlook, By Lead Optimization (2019-2028) (US $MN)
Table 21 Global Drug Discovery Informatics Market Outlook, By First Human Dose (FHD) Preparation (2019-2028) (US $MN)
Table 22 Global Drug Discovery Informatics Market Outlook, By Phase IA Informatics (2019-2028) (US $MN)
Table 23 Global Drug Discovery Informatics Market Outlook, By Phase IB/2 Informatics (2019-2028) (US $MN)
Table 24 Global Drug Discovery Informatics Market Outlook, By Modality (2019-2028) (US $MN)
Table 25 Global Drug Discovery Informatics Market Outlook, By Cloud Based Systems (2019-2028) (US $MN)
Table 26 Global Drug Discovery Informatics Market Outlook, By In Campus Platform (2019-2028) (US $MN)
Table 27 Global Drug Discovery Informatics Market Outlook, By Application (2019-2028) (US $MN)
Table 28 Global Drug Discovery Informatics Market Outlook, By Drug Discovery (2019-2028) (US $MN)
Table 29 Global Drug Discovery Informatics Market Outlook, By Preclinical Testing (2019-2028) (US $MN)
Table 30 Global Drug Discovery Informatics Market Outlook, By Clinical Trials (2019-2028) (US $MN)
Table 31 Global Drug Discovery Informatics Market Outlook, By Drug Development (2019-2028) (US $MN)
Table 32 Global Drug Discovery Informatics Market Outlook, By End User (2019-2028) (US $MN)
Table 33 Global Drug Discovery Informatics Market Outlook, By Academic Institutes (2019-2028) (US $MN)
Table 34 Global Drug Discovery Informatics Market Outlook, By Biotechnology Companies (2019-2028) (US $MN)
Table 35 Global Drug Discovery Informatics Market Outlook, By Contract Research Organization (CROs) (2019-2028) (US $MN)
Table 36 Global Drug Discovery Informatics Market Outlook, By Government Organizations (2019-2028) (US $MN)
Table 37 Global Drug Discovery Informatics Market Outlook, By Hospital (2019-2028) (US $MN)
Table 38 Global Drug Discovery Informatics Market Outlook, By Pharmaceutical Companies (2019-2028) (US $MN)
Table 39 Global Drug Discovery Informatics Market Outlook, By University (2019-2028) (US $MN)
Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner as above.
